We are live on ! Find out more
HEC

Hudson Executive Capital Portfolio holdings

AUM $151M
1-Year Est. Return 60.14%
This Fund
S&P 500
This Quarter Est. Return
-14.89%
1 Year Est. Return
+60.14%
3 Year Est. Return
+143.92%
5 Year Est. Return
+104.85%
10 Year Est. Return
+677.02%
AUM
$434M
AUM Growth
+$117M
Cap. Flow
+$164M
Cap. Flow %
37.85%
Top 10 Hldgs %
96.33%
Holding
12
New
5
Increased
6
Reduced
Closed

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Financials 21.05%
2 Healthcare 13.78%
3 Consumer Staples 7.35%
4 Technology 5.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPY icon
1
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$787B
$139M 31.96%
675,000
+182,900
+37% +$35.7M
CMA
2
DELISTED
Comerica
CMA
$54.1M 12.47%
1,429,000
+91,000
+7% +$3.28M
THC icon
3
Tenet Healthcare
THC
$16.8B
$42.7M 9.84%
1,476,411
CIT
4
DELISTED
CIT Group Inc.
CIT
$37.2M 8.58%
1,199,857
+254,000
+27% +$8M
WWAV
5
DELISTED
The WhiteWave Foods Company
WWAV
$31.9M 7.35%
785,334
+69,500
+10% +$2.64M
HTWR
6
DELISTED
HEARTWARE INTERNATIONAL INC COM STK (DE)
HTWR
$27.2M 6.27%
866,258
+346,000
+67% +$11.7M
CIT
7
CALL
DELISTED
CIT Group Inc.
CIT
$25.2M 5.81%
+812,500
New +$25.6M
CCMP
8
DELISTED
CMC Materials, Inc. Common Stock
CCMP
$23.9M 5.52%
585,300
+23,403
+4% +$925K
EGRX
9
CALL
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$19.9M 4.59%
+492,000
New +$31.2M
EGRX
10
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$17.1M 3.94%
+422,000
New +$26.8M
KRE icon
11
PUT
State Street SPDR S&P Regional Banking ETF
KRE
$4.85B
$11.1M 2.55%
+294,100
New +$10.8M
EGRX
12
PUT
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$4.86M 1.12%
+120,000
New +$7.61M

Similar funds

Hudson Executive Capital's Q1 2016 Portfolio in Review

As of Q1 2016, Hudson Executive Capital held 12 positions worth $434M, up 37% from $317M the previous quarter. Its ten largest holdings account for 96% of the portfolio.

Hudson Executive Capital deployed $164M of net new capital in Q1 2016, opening 5 new positions and adding to 6 existing holdings. Its largest new stake was Eagle Pharmaceuticals, Inc.: 422,000 shares worth $17.1M.

By sector, the portfolio is most concentrated in Financials at 21% of assets, down from 29% a quarter earlier, followed by Healthcare and Consumer Staples.

  • Hudson Executive Capital's largest Q1 2016 buy was Eagle Pharmaceuticals, Inc.: 422,000 shares worth $17.1M.
  • Hudson Executive Capital added most to HEARTWARE INTERNATIONAL INC COM STK (DE) in Q1 2016, an estimated $11.7M increase.
  • Hudson Executive Capital's ten largest holdings make up 96% of its $434M portfolio in Q1 2016.
  • Hudson Executive Capital opened 5 new positions and closed 0 in Q1 2016.
  • Hudson Executive Capital's portfolio value rose 37% quarter-over-quarter to $434M.

Based on Hudson Executive Capital's 13F filing for Q1 2016, filed 16 May 2016.